FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders
The U.S. Food and Drug Administration recently published a new draft guidance to assist sponsors in developing treatments for stimulant use disorders. The guidance, Stimulant Use Disorders: Developing Drugs for …
FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders Read More